Press release
Drug Repurposing Market : Accelerating Innovation and Reducing Costs in Drug Discovery
IntroductionDrug repurposing, also known as drug repositioning or reprofiling, is the process of finding new therapeutic uses for existing drugs. Unlike traditional drug discovery, which may take 10-15 years and billions of dollars, repurposing allows researchers to leverage known safety profiles and pharmacological data, significantly reducing development time, cost, and risk.
With the global burden of cancer, neurological disorders, infectious diseases, and rare conditions growing rapidly, drug repurposing is gaining momentum as a strategy to deliver effective treatments faster. Supported by advanced computational tools, artificial intelligence (AI), and collaborative R&D models, the market is positioned for strong expansion through 2034.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72908
Market Overview
• Market Size (2024): USD 34.7 billion (estimated)
• Forecast (2034): USD 89.5 billion
• CAGR (2024-2034): ~9.8%
Key Growth Drivers:
• Rising healthcare costs driving demand for faster and cheaper drug development.
• Increasing prevalence of chronic diseases and unmet medical needs.
• Integration of AI, machine learning, and big data analytics in repurposing pipelines.
• Government and nonprofit funding for rare disease research.
Challenges:
• Intellectual property (IP) and patentability concerns.
• Regulatory hurdles for new indications.
• Limited commercial incentives for off-patent drugs.
Leading Companies:
Pfizer Inc., Novartis AG, Sanofi, Takeda Pharmaceutical, Teva Pharmaceuticals, GlaxoSmithKline (GSK), Roche, Bayer AG, Eli Lilly and Company, Merck & Co.
Segmentation Analysis
By Approach
• Disease-Centered Approach (testing existing drugs for specific conditions)
• Target-Based Approach (repurposing drugs to act on known molecular targets)
• Computational/AI-Based Approach
• Experimental Screening
By Therapeutic Area
• Oncology
• Neurology (Alzheimer's, Parkinson's, Multiple Sclerosis)
• Infectious Diseases (COVID-19, HIV, Tuberculosis)
• Cardiovascular Disorders
• Rare Diseases & Orphan Conditions
• Others (Autoimmune, Dermatology, Metabolic)
By Drug Status
• Off-Patent/Generic Drugs
• Patented Drugs
By End User
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)
• Nonprofit & Government Organizations
Summary:
The oncology segment dominates revenue due to a strong focus on cancer drug repurposing. Neurology and rare disease segments are expected to grow at the fastest pace, as AI-driven repurposing accelerates discovery in these complex areas.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72908/drug-repurposing-market
Regional Analysis
North America
• Largest market in 2024, with strong government support (NIH, FDA initiatives).
• Presence of major pharma companies and AI-driven startups.
Europe
• EU funding for rare diseases and growing collaborations between academia and industry.
• Germany, UK, and Switzerland are leading hubs.
Asia-Pacific
• Fastest-growing region (CAGR ~11%).
• Expanding biotech ecosystems in China, India, Japan, and South Korea.
• Rising prevalence of chronic and infectious diseases fuels adoption.
Middle East & Africa
• Early adoption phase, but expanding clinical trials in GCC countries.
• South Africa emerging as a hub for infectious disease-focused repurposing.
Latin America
• Brazil and Mexico leading research initiatives in oncology and infectious diseases.
• Government programs supporting affordable drug development.
Summary:
While North America and Europe dominate, Asia-Pacific will see the strongest growth, driven by rising healthcare investments and local partnerships in computational repurposing.
Market Dynamics
Key Growth Drivers
• Lower risk compared to traditional drug development.
• Increasing global collaborations for rare and orphan diseases.
• Growing use of real-world evidence and computational modeling.
• Strong interest in pandemic preparedness and emerging infections.
Key Challenges
• Patent exclusivity concerns for off-patent drugs.
• Difficulties in establishing pricing and reimbursement models.
• Regulatory uncertainty across regions.
Latest Trends
• AI-powered repurposing platforms (e.g., BenevolentAI, Insilico Medicine).
• COVID-19 lessons accelerating interest in antiviral drug repurposing.
• Collaborative consortium models involving academia, pharma, and government.
• Expanding use of omics data and network pharmacology for drug-target identification.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72910
Competitor Analysis
Major Players:
• Pfizer Inc.
• Novartis AG
• Sanofi
• Takeda Pharmaceutical
• Teva Pharmaceuticals
• GlaxoSmithKline (GSK)
• Roche
• Bayer AG
• Eli Lilly and Company
• Merck & Co.
Competitive Landscape:
The market is fragmented but rapidly evolving, with large pharmaceutical firms leveraging repurposing strategies to extend product lifecycles, while startups and AI-driven biotech firms are pioneering computational discovery. Collaborations between academia, non-profits, and big pharma are accelerating repurposing pipelines, especially in oncology and infectious diseases.
Conclusion
The drug repurposing market is projected to expand from USD 34.7 billion in 2024 to USD 89.5 billion by 2034, at a CAGR of 9.8%. By enabling faster, cheaper, and safer drug development, repurposing is becoming a cornerstone of modern pharmaceutical strategy.
Although IP and regulatory hurdles pose challenges, advances in AI, big data, and collaborative models are driving strong momentum. With Asia-Pacific emerging as a high-growth region and oncology, neurology, and rare diseases at the forefront, drug repurposing will play a transformative role in the next decade of medicine.
Key Takeaway: Companies that integrate AI-driven analytics, strategic collaborations, and patient-focused R&D into their repurposing pipelines will lead the way in shaping future healthcare innovation.
This report is also available in the following languages : Japanese (薬物の再利用), Korean (약물 재활용), Chinese (药物再利用), French (Réutilisation des médicaments), German (Umwidmung von Medikamenten), and Italian (Riutilizzo dei farmaci), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72908
Our More Reports:
Non-Tyrosine Kinase Inhibitors
https://exactitudeconsultancy.com/reports/73178/non-tyrosine-kinase-inhibitors-market
Dendritic Cell Therapies
https://exactitudeconsultancy.com/reports/73180/dendritic-cell-therapies-market
Novel Hypercholesterolemia Drugs
https://exactitudeconsultancy.com/reports/73182/novel-hypercholesterolemia-drugs-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Drug Repurposing Market : Accelerating Innovation and Reducing Costs in Drug Discovery here
News-ID: 4205578 • Views: …
More Releases from Exactitude Consultancy
Vacuum Insulated Pipe Market Projected to Reach USD 2.36 Billion by 2034
Introduction: A Market Built on Cryogenic Efficiency and Innovation
The global Vacuum Insulated Pipe (VIP) market is witnessing a steady surge driven by the expanding cryogenic industry, increased liquefied natural gas (LNG) trade, and rising demand for efficient liquid gas transportation systems. These specialized double-wall pipes, engineered with high vacuum insulation between inner and outer layers, have become indispensable in industries handling cryogenic fluids such as liquid nitrogen, oxygen, argon, and…
Solar PV Mounting Systems Market is Expected to Reach USD 31.7 Billion by 2034
Introduction: Powering the Next Decade of Solar Expansion
The Solar PV Mounting Systems Market is emerging as a crucial pillar in the clean energy revolution, enabling efficient, cost-effective, and durable installations of photovoltaic (PV) modules across rooftops, open fields, and floating structures. As the world accelerates toward carbon neutrality, the demand for robust, modular, and adaptable mounting systems has intensified across residential, commercial, and utility-scale solar projects.
Download Full PDF Sample Copy…
Tall Oil Fatty Acid Market projected to reach USD 2.21 billion by 2034
Introduction: A Sustainable Feedstock Powering the Future of Bio-based Chemicals
The Tall Oil Fatty Acid (TOFA) Market is gaining strong traction as industries increasingly shift toward renewable, sustainable, and bio-based chemical alternatives. Derived as a byproduct from the kraft pulping process of pine wood, TOFA has become a vital raw material in the production of alkyd resins, dimer acids, lubricants, coatings, and adhesives. Its unique composition-rich in oleic and linoleic acids-makes…
Lithium-Ion Battery Recycling Market Projected to Reach USD 27.3 Billion by 2034
Introduction: Powering the Circular Energy Transition
As the world accelerates toward electrification and clean energy, the demand for lithium-ion batteries has skyrocketed-fueling everything from electric vehicles (EVs) to smartphones and grid storage systems. However, this exponential growth brings with it an urgent environmental challenge: how to sustainably manage end-of-life batteries.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/25354
The Lithium-Ion Battery Recycling Market has emerged as a cornerstone of the global…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
